- Home
- DXCM vs WST Comparison
DXCM vs WST Comparison
Compare DXCM & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- WST
- Stock Information
- Founded
- DXCM 1999
- WST 1923
- Country
- DXCM United States
- WST United States
- Employees
- DXCM N/A
- WST N/A
- Industry
- DXCM Medical/Dental Instruments
- WST Medical/Dental Instruments
- Sector
- DXCM Health Care
- WST Health Care
- Exchange
- DXCM Nasdaq
- WST Nasdaq
- Market Cap
- DXCM 28.0B
- WST 24.5B
- IPO Year
- DXCM 2005
- WST N/A
- Fundamental
- Price
- DXCM $75.88
- WST $314.52
- Analyst Decision
- DXCM Buy
- WST Buy
- Analyst Count
- DXCM 17
- WST 3
- Target Price
- DXCM $101.29
- WST $460.33
- AVG Volume (30 Days)
- DXCM 5.0M
- WST 799.9K
- Earning Date
- DXCM 10-24-2024
- WST 10-24-2024
- Dividend Yield
- DXCM N/A
- WST 0.27%
- EPS Growth
- DXCM 83.21
- WST N/A
- EPS
- DXCM 1.67
- WST 6.74
- Revenue
- DXCM $3,954,000,000.00
- WST $2,876,400,000.00
- Revenue This Year
- DXCM $13.10
- WST N/A
- Revenue Next Year
- DXCM $14.82
- WST $6.22
- P/E Ratio
- DXCM $45.51
- WST $46.66
- Revenue Growth
- DXCM 16.19
- WST N/A
- 52 Week Low
- DXCM $62.34
- WST $265.00
- 52 Week High
- DXCM $142.00
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- DXCM 64.11
- WST 49.46
- Support Level
- DXCM $71.75
- WST $324.61
- Resistance Level
- DXCM $75.47
- WST $347.53
- Average True Range (ATR)
- DXCM 2.37
- WST 11.05
- MACD
- DXCM 0.52
- WST 0.74
- Stochastic Oscillator
- DXCM 78.60
- WST 16.73
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.